BioHarvest Sciences Inc.
BHST
$1.90
-$0.01-0.52%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.84M | 8.51M | 9.07M | 9.07M | 8.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.84M | 8.51M | 9.07M | 9.07M | 8.52M |
| Cost of Revenue | 3.76M | 3.47M | 3.84M | 3.50M | 3.43M |
| Gross Profit | 5.08M | 5.04M | 5.23M | 5.57M | 5.09M |
| SG&A Expenses | 5.93M | 5.48M | 5.05M | 5.06M | 5.56M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.34M | 10.34M | 10.19M | 9.99M | 10.33M |
| Operating Income | -2.51M | -1.83M | -1.12M | -920.00K | -1.82M |
| Income Before Tax | -3.66M | -2.60M | -2.27M | -2.45M | -4.04M |
| Income Tax Expenses | 52.00K | 46.00K | -64.00K | 63.00K | 39.00K |
| Earnings from Continuing Operations | -3.72M | -2.64M | -2.20M | -2.51M | -4.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.72M | -2.64M | -2.20M | -2.51M | -4.08M |
| EBIT | -2.51M | -1.83M | -1.12M | -920.00K | -1.82M |
| EBITDA | -2.02M | -1.41M | -1.01M | -535.00K | -1.41M |
| EPS Basic | -0.16 | -0.12 | -0.10 | -0.14 | -0.24 |
| Normalized Basic EPS | -0.10 | -0.07 | -0.07 | -0.09 | -0.15 |
| EPS Diluted | -0.16 | -0.12 | -0.10 | -0.14 | -0.24 |
| Normalized Diluted EPS | -0.10 | -0.07 | -0.07 | -0.09 | -0.15 |
| Average Basic Shares Outstanding | 22.67M | 22.67M | 21.38M | 17.42M | 17.33M |
| Average Diluted Shares Outstanding | 22.67M | 22.67M | 21.38M | 17.42M | 17.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |